Jupiter Research Capital (Asia) Ltd’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,604
Closed -$265K – 985
2026
Q2
$265K Sell
5,604
-921
-14% -$47.3K 0.03% 574
2026
Q1
$387K Buy
6,525
+314
+5% +$20.4K 0.04% 451
2025
Q4
$383K Buy
+6,211
New +$380K 0.08% 347

Other funds holding PBH

Jupiter Research Capital (Asia) Ltd's PBH Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Prestige Consumer Healthcare (PBH) in Q3 2026, closing a stake of 5,604 shares — an estimated $265K sold.

Jupiter Research Capital (Asia) Ltd first reported a position in PBH in Q4 2025 and held it in 3 quarters. The position peaked at $387K in Q1 2026. 317 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Prestige Consumer Healthcare position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 5,604 Prestige Consumer Healthcare shares in Q3 2026, an estimated $265K.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Prestige Consumer Healthcare in Q4 2025 and held it in 3 quarters.
  • Jupiter Research Capital (Asia) Ltd's Prestige Consumer Healthcare position peaked at $387K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.